Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Kivitz

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Cleveland Clinic Journal of Medicine|December 13, 2016
Minocycline-induced hyperpigmentationMahmoud Abdelghany, Alan J Kivitz
The Journal of the American Osteopathic Association|November 19, 2003
Management of postmenopausal osteoporosisFrederick T Murphy, Alan J Kivitz, Earl E Sands
The Journal of Rheumatology|February 17, 2007
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumabJeffrey L Kaine, Alan J Kivitz, Charles Birbara, et al.
SAGE Open Medicine|January 16, 2016
Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritisJaime A Pachon, Alan J Kivitz, Kay-Uwe Heuer, et al.
Seminars in Arthritis and Rheumatism|March 10, 2019
Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapyLeonard H Calabrese, Paul Emery, Alan J Kivitz, et al.
Clinical Therapeutics|May 9, 2006
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptomsGary W Williams, Alan J Kivitz, Mark T Brown, et al.
Arthritis and Rheumatism|December 13, 2005
Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the kneeThomas J Schnitzer, Alan J Kivitz, Robert S Lipetz, et al.
Rheumatology and Therapy|April 16, 2024
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE StudiesAlan J Kivitz, Joel M Kremer, Clarence W Legerton, et al.
Pain and Therapy|May 9, 2019
Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical TrialsAlan J Kivitz, Philip G Conaghan, Amy Cinar, et al.
Arthritis Care & Research|August 29, 2013
Twice daily versus once nightly dosing of pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safetyKeaton Nasser, Alan J Kivitz, Michael J Maricic, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Cleveland Clinic Journal of Medicine|December 13, 2016
Minocycline-induced hyperpigmentationMahmoud Abdelghany, Alan J Kivitz
The Journal of the American Osteopathic Association|November 19, 2003
Management of postmenopausal osteoporosisFrederick T Murphy, Alan J Kivitz, Earl E Sands
The Journal of Rheumatology|February 17, 2007
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumabJeffrey L Kaine, Alan J Kivitz, Charles Birbara, et al.
SAGE Open Medicine|January 16, 2016
Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritisJaime A Pachon, Alan J Kivitz, Kay-Uwe Heuer, et al.
Seminars in Arthritis and Rheumatism|March 10, 2019
Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapyLeonard H Calabrese, Paul Emery, Alan J Kivitz, et al.
Clinical Therapeutics|May 9, 2006
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptomsGary W Williams, Alan J Kivitz, Mark T Brown, et al.
Arthritis and Rheumatism|December 13, 2005
Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the kneeThomas J Schnitzer, Alan J Kivitz, Robert S Lipetz, et al.
Rheumatology and Therapy|April 16, 2024
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE StudiesAlan J Kivitz, Joel M Kremer, Clarence W Legerton, et al.
Pain and Therapy|May 9, 2019
Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical TrialsAlan J Kivitz, Philip G Conaghan, Amy Cinar, et al.
Arthritis Care & Research|August 29, 2013
Twice daily versus once nightly dosing of pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safetyKeaton Nasser, Alan J Kivitz, Michael J Maricic, et al.
Pageof 10